文献速递腹部MR

增强包膜与改良包膜表现在LI-RADS诊断≤3.0 cm HCC中的价值

The role of enhancing capsule and modified capsule appearances in LI-RADS for diagnosing HCC ≤ 3.0 cm on gadoxetate disodium-enhanced MRI.
PubMed 文献 · Eur Radiol · 2023-03-10

回顾性纳入319例患者342个≤3.0 cm肝脏病灶,评估钆塞酸二钠增强MRI上增强包膜或改良包膜表现作为LI-RADS主要特征诊断HCC的价值。增强包膜提高诊断敏感度且不降低特异度;非增强包膜作为替代包膜表现具有更好的阅片者间一致性及相当的诊断效能。

要点

  • 增强包膜作为主要特征可提高LI-RADS诊断≤3.0 cm HCC的敏感度。
  • 非增强包膜可作为替代包膜表现,阅片一致性优于冠状强化。
  • 包膜表现无论增强或非增强均应视为诊断HCC的主要特征。

核心结论

  • 增强包膜表现提高了钆塞酸二钠增强MRI上LI-RADS诊断≤3.0 cm HCC的敏感度。
  • 非增强包膜作为替代包膜表现可获得更好的阅片者间一致性和相当的诊断效能。

研究设计与样本

  • 回顾性研究纳入319例患者342个≤3.0 cm肝脏病灶,均行钆塞酸二钠增强MRI。
  • 比较LI-RADS、忽略增强包膜的LI-RADS及两种改良LI-RADS的诊断效能,并行Bonferroni校正。
  • 采用多变量回归分析识别与组织学纤维包膜相关的独立特征。

关键影像表现/征象

  • 增强包膜的阅片者间一致性为0.64,低于非增强包膜替代的0.71,高于冠状强化替代的0.58。
  • 增强包膜和非增强包膜均与组织学纤维包膜显著相关(p < 0.05)。

诊断标准与关键数值

  • 忽略增强包膜后LI-RADS诊断HCC敏感度从72.7%降至67.4%(p < 0.001),特异度89.3% vs. 90.7%(p = 1.000)。
  • 两种改良LI-RADS较LI-RADS敏感度略高、特异度略低,均无统计学意义(所有p ≥ 0.006)。
  • 改良LI-RADS联合非增强包膜的AUC最高,为0.82。

临床应用与阅片要点

  • 阅片时应将包膜表现(无论增强或非增强)作为LI-RADS诊断≤3.0 cm HCC的主要特征。
  • 非增强包膜可作为增强包膜的替代表现,有助于提高阅片者间一致性。

局限性

  • 本研究为回顾性单中心设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the value of using enhancing capsule (EC) or modified capsule appearance as a major feature in LI-RADS for diagnosing HCC ≤ 3.0 cm on gadoxetate disodium-enhanced MRI (Gd-EOB-MRI), and to explore the relationship between the imaging features and the histological fibrous capsule.

METHODS: This retrospective study enrolled 342 hepatic lesions ≤ 3.0 cm in 319 patients that underwent Gd-EOB-MRIs from January 2018 to March 2021. During dynamic phases and hepatobiliary phase, the modified capsule appearance added the nonenhancing capsule (NEC) (modified LI-RADS + NEC) or corona enhancement (CoE) (modified LI-RADS + CoE) to EC as an alternative capsule appearance. Inter-reader agreement of imaging features was assessed. The diagnostic performances of LI-RADS, LI-RADS with EC ignored, and two modified LI-RADS were compared, followed by Bonferroni correction. Multivariable regression analysis was performed to identify the independent features associated with the histological fibrous capsule.

RESULTS: The inter-reader agreement on EC (0.64) was lower than that on the NEC alternative (0.71) but better than that on CoE alternative (0.58). For HCC diagnosis, compared to LI-RADS, LI-RADS with EC ignored showed significantly lower sensitivity (72.7% vs. 67.4%, p < 0.001) with comparable specificity (89.3% vs. 90.7%, p = 1.000). Two modified LI-RADS showed slightly higher sensitivity and lower specificity than LI-RADS, without statistical significance (all p ≥ 0.006). The AUC was highest with modified LI-RADS + NEC (0.82). Both EC and NEC were significantly associated with the fibrous capsule (p < 0.05).

CONCLUSION: EC appearance improved the diagnostic sensitivity of LI-RADS for HCC ≤ 3.0 cm on Gd-EOB-MRI. Considering NEC as an alternative capsule appearance allowed for better inter-reader reliability and comparable diagnostic ability.

KEY POINTS: • Using the enhancing capsule as a major feature in LI-RADS significantly improved the sensitivity of diagnosing HCC ≤ 3.0 cm without reducing specificity on gadoxetate disodium-enhanced MRI. • Compared to the corona enhancement, the nonenhancing capsule might be a preferable alternative capsule appearance for diagnosing HCC ≤ 3.0 cm. • Capsule appearance should be considered a major feature in LI-RADS for diagnosing HCC ≤ 3.0 cm, regardless whether the capsule appears to be enhancing or nonenhancing.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Pan, Song, Yang, et al. The role of enhancing capsule and modified capsule appearances in LI-RADS for diagnosing HCC ≤ 3.0 cm on gadoxetate disodium-enhanced MRI. Eur Radiol. 2023. PMID: 36894754. doi:10.1007/s00330-023-09487-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。